News > Fact vs. fiction: The truth about genetic testing

Fact vs. fiction: The truth about genetic testing

Stylized stock image of DNA strands, a computer keyboard, and a person's face

Whether you’re at high risk, newly diagnosed, or being treated for breast cancer, you may want to talk with your health care team about genetic testing for inherited mutations. Meanwhile, there are several misconceptions people have about genetic testing; here are seven common myths, as well as the facts behind them:

Myth 1: Only young women with breast cancer should get genetic testing.

Fact: The National Comprehensive Cancer Network (NCCN) recommends genetic testing for inherited mutations after a breast cancer diagnosis for women and those assigned female at birth of all ages whose families are Ashkenazi Jewish (from Central and Eastern Europe); men of all ages; and people of all ages with certain subtypes of breast cancer or with at least one close relative with male breast cancer.

Myth 2: Only people with triple-negative breast cancer need genetic testing for an inherited mutation.

Fact: Testing isn't just for people with TNBC. NCCN recommends genetic testing for an inherited mutation for people diagnosed with lobular breast cancers, which are commonly hormone receptor-positive, who have a personal or family history of diffuse gastric cancer.

Myth 3: Genetic testing doesn’t offer information that can be used to make treatment decisions.

Fact: Testing positive for a BRCA1 or BRCA2 gene mutation can influence treatment options for both surgery and medicine, whether you’ve been diagnosed with breast cancer or not – and regardless of the cancer stage.

Surgery: Testing positive for either BRCA gene mutation (among others), even without a breast cancer diagnosis, means you may benefit from a prophylactic, or preventive, mastectomy. With a positive result after a diagnosis, you could choose to have the unaffected (healthy) breast removed preventively.

BRCA1/2 are also associated with a high risk for ovarian cancer, so many doctors recommend women with either gene mutation have a preventive oophorectomy – surgery to remove the ovaries. (NCCN provides testing criteria for other susceptibility genes, including pancreatic, prostate, and colorectal cancers.)

Medicine: Targeted therapies called PARP inhibitors can be used to treat hereditary breast cancers. One of these drugs, olaparib (Lynparza), is FDA approved for people diagnosed with certain breast cancers, such as metastatic and early-stage HER2-negative breast cancer – who have a BRCA1 or BRCA2 mutation. In metastatic breast cancer, another PARP inhibitor, talazoparib (Talzenna) is also available.

Myth 4: Only white people need to be tested.

Fact: People of color can and do test positive for hereditary gene mutations. The racial disparities that exist in cancer research and care also exist for genetic testing for inherited mutations. While research hasn't clearly proved racial differences in the frequency of inherited breast cancer gene mutations, Black women are less likely to be referred for genetic testing than white women, and Hispanic women are less likely to be referred than non-Hispanic women.

Myth 5: Health insurance won’t cover genetic counseling or testing.

Fact: Insurance plans must cover genetic counseling for women at increased risk for breast cancer; many will cover testing if a doctor recommends it. Consult with your doctor about your options.

Myth 6: If my health insurance company knows I have a genetic mutation, I will be uninsurable.

Fact: It is illegal for insurance companies to deny coverage to people who have tested positive for genetic mutations, per the Genetic Information Nondiscrimination Act.

Myth 7: Since I can get an at-home test, I don’t need to talk with a genetic counselor.

Fact: A genetic counselor can help you decide if testing is a good choice for you and can help you understand the relevance and limitations of the results. Results from at-home tests often don’t give enough information for most people to know what they mean (even when they come back negative) or to puzzle through next steps – if any – to take. Counselors are trained to understand the results and help make other choices or treatment decisions based on test findings.

The field of genetic testing for inherited mutations has progressed significantly over the years. Scientists continue to further their understanding of genetic predisposition, and they hope to find better, more targeted ways to prevent, identify, and treat cancer in people who carry the genetic mutations that increase risk.

For more information:

Did you know that breast cancer and prostate cancer can be linked? Get the facts #GetScreenedTogether here.


Additional resources

High-risk / Concerned

03/15/22 | BY: Virginia Kaklamani

Some people are more likely than others to be diagnosed with breast cancer. Previvor is a term that’s often used to describe people who have a high risk of developing breast cancer.

Read More | 16 Min. Read |

Genetics and family risk

10/07/19 | BY: Mark Robson

According to the National Cancer Institute, 1 in 8 American women will develop breast cancer in her lifetime. Certain genes, small pieces of your DNA, can cause breast cancer to grow when they have a mutation , or error.

Read More | 8 Min. Read |

Signs breast cancer may be BRCA-related

08/20/19 | BY: Mark Robson

Certain patterns in your family’s health history may suggest that you or your relatives carry a gene mutation linked to breast cancer.

Read More | 7 Min. Read |

Genetics and male breast cancer

10/24/16 | BY: William F. Anderson, Sharon H. Giordano, Kathryn Ruddy

About 10 percent of men diagnosed with breast cancer have a breast cancer-related genetic mutation, most commonly in the BRCA1 or BRCA2 gene. Everyone has the BRCA1 and BRCA2 gene. But errors in the gene, called mutations, are linked to hereditary breast cancer.

Read More | 3 Min. Read

Sharing your genetic test results at work

08/31/15 | BY: Jennifer Ivanovich, Rebecca Mueller, Bert Petersen, Mark Robson

Though you may need to take time off for genetic testing just as you would for a doctor’s appointment, you don’t have to share your medical or genetic information with your employers. Your results, as well as the testing process, are personal.

Read More | 4 Min. Read

Sharing your genetic test results with family

08/31/15 | BY: Jennifer Ivanovich, Rebecca Mueller, Bert Petersen, Mark Robson

Though genetic testing is highly personal, it may be important to you or your family to share what you’ve learned from your results. Communicating such important and sensitive information can be stressful, but it can also offer you relief by sharing your burden.

Read More | 7 Min. Read

Genetic testing and your relationships

08/31/15 | BY: Jennifer Ivanovich, Rebecca Mueller, Bert Petersen, Mark Robson

Taking the first step to see a genetic counselor or moving forward with genetic testing may leave you feeling everything from empowered to anxious.

Read More | 7 Min. Read

Genetic test results and what they mean

08/31/15 | BY: Mark Robson, A. Jo Chien

Your results will tell you whether you are positive for a gene mutation, meaning you carry the mutation; are negative for a gene mutation, meaning a mutation was not found; or express a variant of uncertain significance, a change in the gene that may or may not increase your cancer risk.

Read More | 6 Min. Read

Genetic testing

08/31/15 | BY: Mark Robson

If you are newly diagnosed with breast cancer, knowing whether you carry a gene mutation may help you make important treatment decisions. Many women choose to have genetic testing even after they complete treatment to better understand their risk for a second breast cancer or ovarian cancer. 

Read More | 8 Min. Read

Genetic test results and treatment decisions

08/31/15 | BY: Mark Robson

Whether you are newly diagnosed or post-treatment, your genetic testing results may influence treatment decisions you make now or in the future. Positive, negative and uncertain results each affect decision-making in their own way.

Read More | 7 Min. Read

Stay connected

Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.